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Severity of sterile inflammation, as seen in acute pancreatitis, is determined by damage-
sensing receptors, signalling cascades and cytokine production. Stat2 is a type I interferon 
signalling mediator that also has interferon-independent roles in murine lipopolysaccharide-
induced NF-B-mediated sepsis. However its role in sterile inflammation is unknown.  We 
hypothesised that Stat2 determines severity of non-infective inflammation in the pancreas.  
Wild type (WT) and Stat2-/- mice were injected intraperitoneally with caerulein or L-arginine.  
Specific cytokine-blocking antibodies were used in some experiments. Pancreata and blood 
were harvested 1 h and 24 h after the final dose of caerulein and up to 96 h post L-arginine.  
Whole-tissue phosphoproteomic changes were assessed using label-free mass spectrometry.  
Tissue-specific Stat2 effects were studied in WT/Stat2-/- bone-marrow chimera and using Cre-
lox recombination to delete Stat2 in pancreatic and duodenal homeobox 1(Pdx1)-expressing 
cells. 
Stat2-/- mice were protected from caerulein- and L-arginine-induced pancreatitis. Protection 
was independent of type I interferon signalling. Stat2-/- mice had lower cytokine levels 
including TNF and IL-10 and reduced NF-kB nuclear localisation in pancreatic tissue 
compared to WT.  Inhibition of TNF improved (inhibition of IL-10 worsened) caerulein-
induced pancreatitis in WT but not Stat2-/- mice.  Phosphoproteomics showed down-
regulation of mitogen-activated protein kinase (MAPK) mediators but accumulation of 
Ser412-phosphorylated Tak1.  Stat2 deletion in Pdx1-expressing acinar cells (Stat2flox/Pdx1-cre) 
reduced pancreatic TNF expression, but not histological injury or serum amylase.  WT/Stat2-
/- bone-marrow chimera were protected from pancreatitis irrespective of host or recipient 
genotype.   
Stat2 loss results in disrupted signalling in pancreatitis, upstream of NF-B in non-acinar 
and/or bone marrow derived cells.   
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INTRODUCTION 
The response to tissue damage involves signalling pathways such as Toll-like receptors, 
mitogen activated protein (MAP) kinases and transcription factors such as NF-B [1]. 
Transcription factor activation initiates inflammatory and healing processes by 
producing pro- and anti-inflammatory cytokines that include TNF, interleukins and 
interferons (IFN), which also serve to amplify the inflammatory response through their 
own signalling pathways.  Stat2 is a mediator of type I IFN signalling, but it is 
increasingly evident that Stat2 has a key role in mediating inflammatory responses 
beyond this pathway [2, 3]. We have previously demonstrated an IFN-independent role 
for Stat2, but not other Stat proteins, in the response to bacteria- and virus-derived 
molecular patterns and in a mouse model of sepsis [4]. However, its role in non-
infective inflammation, which is a characteristic of acute pancreatitis, has received 
scant attention to date.  
Acute pancreatitis (AP) is a clinically significant example of damage-induced or ‘sterile’ 
inflammation. It is a potentially life-threatening, highly unpredictable and increasingly 
common inflammatory disease [5, 6] with no specific treatment.  Production and 
activity of inflammatory cytokines are central to the pathogenesis of AP [7], but a 
number of challenges exist to studying acute pancreatitis in humans, especially in the 
early, initiating stages of disease. These include the inaccessibility of pancreatic tissue 
and a variable time interval between onset of symptoms and presentation to hospital.  
Mouse models can be used to address both of these challenges, but no single model 
recapitulates all the features of acute pancreatitis seen in man. Injection with 
supraphysiological concentrations of caerulein activates intracellular signalling and 
metabolic pathways that generate toxic mediators that cause a rapid mild pancreatitis.  
Injection with L-arginine causes a much more severe inflammation and can 
recapitulate later or secondary events in human pancreatitis.  
To date, studies of type I IFN in the pathogenesis of pancreatitis have focused on 
known canonical functions of the type I IFN receptor (Ifnar) and signalling [8], but not 
Stat2. In the current study, we tested the hypothesis that Stat2-mediated signalling 
plays a role in AP as a model of non-infective tissue inflammation. 
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We have found that Stat2 loss is protective against pancreatic injury in two 
independent models of AP in mice.  Stat2 loss was associated with reduced expression 
of inflammatory cytokine, and inhibiting cytokines can modulate the severity of 
pancreatitis in WT but not Stat2-/- mice. We have used bone-marrow chimera and 
acinar cell-specific deletion of Stat2 to show that, despite the importance of acinar cells 
in cytokine production, non-acinar stromal and / or bone-marrow-derived cells 
determine the severity of tissue inflammation.  This gives us novel insight into the role 
of Stat2 in mediating the severity of inflammation. 
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MATERIALS AND METHODS 
Experimental models of AP 
Generation of Stat2-/- mice was previously described [9]. Mice were housed in a conventional 
facility in individually ventilated cages with free access to food and water. All animal studies 
were performed in accordance with the National Institutes of Health Guide for Care and Use 
of Laboratory Animals and approved the UK Home Office and Local Ethics Committee at 
Queen Mary, University of London.  Patients were not involved in the design of this study. 
Pancreatitis was induced in male and female mice age 6-9 weeks by hourly intraperitoneal 
injections of 50 µg/kg or 100 µg/kg caerulein in PBS for 4 h or 7 h and samples were collected 
at 1 h (hyperacute) and 24 h (acute) after the last injection respectively.  L-arginine-induced 
pancreatitis was induced by 2 intraperitoneal injections of 4 g/kg L-arginine in PBS 1 h apart.  
For some experiments, mice were injected intraperitoneally with 100 µg anti-TNF (Ultra-
LEAF™ Purified anti-mouse TNFα Antibody, clone MP6-XT22 Biolegend) or 200µg 
intraperitoneally (ip) anti-IL-10 (LEAF™ purified anti-mouse IL-10 Antibody, clone JES5-16E3 
Biolegend) 1 h before caerulein treatment. For IFNAR1 blocking experiments, mice were 
injected with 500 µg ip anti-Mouse IFNAR1 Low Endotoxin Functional Formulation (clone 
MAR1-5A3 Universal Biologicals) 24 h before caerulein.  For TNFα stimulation, mice received 
intraperitoneal injections of 2 µg ip TNFα (Peprotech) 24 h before caerulein injections. Control 
mice were injected with PBS alone.  
Mice were euthenased at the end of the experiment by terminal inhalational anaesthesia and 
cervical dislocation.  The abdominal cavity was incised and the pancreas dissected and 
removed. Tissues were snap frozen for protein and RNA extraction or fixed immediately in 
10% formalin and embedded in paraffin blocks for H&E and immunohistochemistry.  Blood 
samples were taken and serum was stored in aliquots at -80 °C until use. Serum amylase levels 
were measured using a Roche Cobas analyser. Tissues were dried following incubation at 56 
°C for 72 h.  
Tissue oedema in the hyperacute experiment was calculated by subtracting dry weight from 
initial wet weight, pancreatic oedema index [10] and assessing Evans Blue density.  Mice were 
injected intravenously 30 min before caerulein treatment with 1% w/v Evans Blue. At the end 
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of the experiment, animals were sacrificed, and tissues were harvested and incubated in 10% 
formamide at 56 °C for 24 h. The amount of accumulated Evans Blue in the tissue supernatant 
was quantified by spectroscopy at 570 nm. 
Bone marrow chimeric mouse production 
Femurs and tibias were harvested from donor mice. The ends of each bone were removed 
and bone marrow cells flushed out with PBS/0.2% FCS. Erythrocytes were removed by 
hypotonic lysis and cells were washed and counted by trypan blue exclusion. Bone marrow 
cells were clarified through a 70 µm cell strainer, resuspended at 5 million cells/ml and kept 
on ice until injection into recipient mice 2 h later. Recipient mice were X-ray irradiated (2 x 5 
Gy) using a RadSource RS-2000. Irradiations were approximately 4h apart, donor cells were 
injected into recipients via the tail vein (1 million cells/mouse) 1 h after the second irradiation. 
Mice were maintained on Baytril-containing drinking water (0.02 mg/ml) for 3 days prior to 
irradiation and up to 2 weeks post cell transfer. Mice were used for experiments 6 weeks after 
cell injection. 
Serum Cytokine ELISA 
Serum was analysed for TNFα, IFN, IL-1β, IL-6, IL-0, IL-17A using a multiplex (6-plex) ELISA 
(BD), and for IL-1B, IL-6 and IL-10 using the mouse magnetic luminex assay (R&D). Serum was 
used as 1:4 dilution in PBS for analysis.  
Quantitative Real-Time PCR 
Tissue samples were sonicated on ice in Trizol (Thermo Fisher) and total RNA was isolated as 
recommended by the manufacturer. RNA concentrations were measured using NanoDrop 
2000 (Thermo Scientific) and normalised across the experiment. cDNA was reverse 
transcribed using the Superscript IV protocol (Invitrogen) and qRT-PCR was performed using 
the rotor-gene SYBR green PCR kit (Qiagen) (see Supplemental Table 1 for gene names and 
sequences used).  Cycle threshold (ct) values were determined for each sample and the ct 
value difference (ct) was used to calculate the factor of differential expression (2ct). 
Correction for cDNA input deviations was performed using beta actin. 
Protein Immunoblots 
 7 
Whole cell extracts were prepared by homogenising tissues in lysis buffer (Tris 50 mM, NaCl 
150 mM, EDTA 2 mM, 1% NP-40) containing Halt™ Protease and Phosphatase Inhibitor 
Cocktail  (Thermo Fisher Scientific). Tissue samples were homogenised on ice, and incubated 
with vigorous shaking at 4 °C for 30 min. Cells were then vortexed and centrifuged for 10 min 
at 13600 rpm at 4 °C. Cytoplasmic and nuclear extracts were prepared. Frozen tissues were 
homogenized in hypotonic buffer A (HEPES 10 mM, pH 7.5, KCl 10 mM, EGTA 0.1 mM, EDTA 
0.1 mM, pH 8.0, 1 mM DTT) containing protease/phosphatase inhibitor cocktail. Cells were 
kept on ice for 10 min, 0.3% NP-40 added, vortexed briefly and spun down for 30 s at 4 °C. 
Supernatant (cytoplasmic fraction) was removed and stored on ice for protein quantification. 
The pellet was washed again with buffer A, and the hypertonic, high-salt buffer C was added 
(HEPES 20 mM, pH 7.5, NaCl 0.4 M, EDTA 1 mM, EGTA 1 mM, glycerol 20%) together with the 
protease/phosphatase inhibitor cocktail. After centrifugation (10 min at 13600 rpm, 4 °C), the 
supernatant was collected and referred to as the nuclear fraction. 
Protein concentration was measured using the Pierce BCA assay as recommended by the 
manufacturer (Thermo Fisher). Aliquots of equal concentration were mixed in 4X sample 
buffer consisting of 277.8 mM Tris-HCl, pH 6.8, 44.4% (v/v) glycerol, 4.4% LDS, 0.02% 
bromophenol blue (Bio-Rad) with additional 50 mM DTT, boiled at 95 °C for 5 min and stored 
at -80 °C. See Supplemental Table 1 for antibodies used. 
Histology/immunocytochemistry 
Sections of formalin fixed paraffin embedded tissues were stained with haematoxylin and 
eosin. Two pathologists, blinded to the treatment,  group scored, digitised, images of the 
whole specimen for oedema (0, absent or rare; 1, oedema in the interlobular space; 2, 
oedema in the intralobular space; and 3, the isolated-island shape of pancreatic acinus), 
inflammation (0, absent; 1, mild; 2, moderate; and 3, severe)  and parenchymal  necrosis (0, 
absent; 1, focal (<5%); 2, and/or sublobular (<20%); 3, and/or lobular (>20%)). Parenchymal 
haemorrhage was not seen.  The first pathologist was asked to re-score the slides in a blinded 
fashion and a second pathologist also blinded, scored the slides independently using the same 
scoring system and intra- and inter-observer kappa scores calculated. Images were taken on 
a Hammamatsu scanner and displayed at 20x magnification. 
Immunofluorescence Microscopy 
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Pancreas cell suspensions were prepared as described [11]. Isolated acinar cells were plated 
onto chamber slides (NUNC) pre-coated with 50 μg/ml type 1 collagen (Thermo Fisher) in 0.02 
M acetic acid, 0.2 μm-filtered and incubated overnight at 37 °C 5% CO2. Cells were treated 
with 10 ng/ml TNFα (Peprotech) or 1 nM CCK (Cambridge Biosciences) for indicated time 
points. Cells were fixed in cold PFA (4% PFA in PBS) for 20 min room temperature. Cells were 
permeabilised in 0.3% Triton X100 in PBS for 10 min and blocked in 5% BSA/PBS for 30 min at 
RT. Cells were incubated with anti-p65 (D14E12) XP® Rabbit mAb CST) primary antibody 
(1:200) in 2% BSA/PBS/0.05% Tween-20 at 4 °C overnight. See Supplemental Table 1 for 
antibodies used. Cells were washed 3X with wash buffer (PBS/0.05% Tween-20) and stained 
with goat anti-rabbit 488 conjugated antibody 1:500 (Thermo Fisher) in in 2% BSA/PBS/0.05% 
Tween-20 for 1 h at RT. Slides were washed in wash buffer 2X and PBS 1X and dehydrated in 
70-100% ethanol series prior to mounting in VECTASHIELD Antifade Mounting Medium with 
DAPI (Vector Laboratories). Confocal images were acquired on Zeiss LSM 710 upright scanning 
confocal microscope using 63X oil objective, numerical aperture 1.4. Z-stacks were acquired 
at 1 µm intervals 20 µm above and below the midline of the cell cluster.  Images were analysed 
using ImageJ and IMARIS (Bitplane) software.   Localisation of indirectly labelled p65 in the 
nuclei was quantified by preparing a 3-D threshold image in DAPI and measuring the mean 
intensity values for the green channel in each nucleus.  
Phosphoproteomic analysis  
Pancreata were crushed, vortexed and sonicated in ice-cold 8M Urea (in 20 mM HEPES pH 
8.0) supplemented with Na3VO4, NaF, Na2P2H2O7 (sodium pyrophosphate) and beta-glycerol 
phosphate. Lysates were reduced, alkylated, and digested overnight. Following desalting by 
solid-phase extraction, 350 g total protein was phosphoenriched using TiO2 beads prior to 
phophoproteomic analysis by liquid chromatography-mass spectrometry as described 
previously [12].   
Statistics 
All serum amylase, ELISA, IMARIS and real-time PCR data were analysed using Prism 
software. Data are presented as mean with error bars reflecting standard error of the mean 
(SEM).   Raw mass spectrometry data were analysed using Proteome Discoverer 1.4.  The 
Mascot search engine (version 2.2.06) was used to automate peptide identification against 
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the SwissProt database.  Fragment tolerance was set at 0.8Da.  Mass spectrometry 
quantitative normalised total spectra for phosphorylation modifications were analysed using 
Scaffold Viewer 4.7.2 (Proteome Software).   Pathway analysis was performed using 
PANTHER gene enrichment software (http://pantherdb.org).  
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RESULTS 
Stat2-/- mice are protected from acute pancreatitis 
To assess the effect of Stat2 on tissue inflammation, AP was induced in WT and Stat2-
/- mice by giving hourly intraperitoneal (i.p) injections of caerulein for 4 h or 7 h. Tissue 
and blood samples were harvested 1 h (which we defined as hyperacute) and 24 h 
(which we defined as acute) after the final injection respectively (Supplemental Fig. 
1A). Stat2-/- mice had significantly lower serum levels of amylase compared to WT 
following hyperacute injury (Fig. 1A, 3808 iU/ml vs 8001 iU/ml, p<0.0001). At this time 
point, pancreatic tissue damage was mild, but there was significantly less pathology (in 
particular oedema) in Stat2-/- mice compared to WT (Fig. 1B, Supplemental Fig. 1B – 
D). In the acute model (7 hourly injections of caerulein and harvesting after 24 h), injury 
was more evident histologically and Stat2-/- mice had less pancreatic necrosis and 
interlobular oedema compared to WT (Fig. 1B), although amylase levels had returned 
to baseline in both genotypes at this time point (not shown). 
We did not find any differences in the expression of the receptors that are activated 
by caerulein (cholecystokinin (CCK)-AR or CCK-BR) between WT and Stat2-/- pancreatic 
extracts that could account for the difference in severity of injury observed 
(Supplemental Fig 1E). Total Stat2 levels in whole cell extracts from whole WT 
pancreata were unaffected by caerulein treatment (Supplemental Fig 1F). We 
excluded the possibility that loss of Stat2 protects from hyperacute caerulein-induced 
pancreatitis through a type I IFN-mediated signalling loop by pre-treating animals with 
500 g/i.p Ifnar-1 blocking antibody. Although the antibody effectively inhibited IFNα-
mediated Mx1 production in splenocytes (Fig 1E), it had no significant impact on 
amylase levels in Stat2-/- mice and did not protect WT mice from caerulein-induced 
pancreatitis (Fig 1F). 
Stat2 loss was protective in a second, more severe model of pancreatitis induced by L-
arginine injection. Stat2-/- mice had lower levels of serum amylase compared to WT 
mice at 24 h and 72 h following L-arginine treatment (8768 iU/ml vs 4829 iU/ml, 
p<0.05, Fig 1E).  L-arginine caused marked pancreatic necrosis, oedema, tissue 
destruction and inflammatory cell infiltration over 96 h in WT mice, that was much less 
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evident in Stat2-/- mice at all time points (Fig. 1F, Supplemental Fig. 1G-H). Intra-
observer kappa score for histology scoring =0.845 and inter-observer kappa=0.746. 
Stat2 mediates acute pancreatitis upstream of cytokine production and activity 
We did not observe clinical signs of systemic inflammation nor significant increases in 
serum concentrations of cytokines in hyperacute or acute caerulein-treated models 
(Supplemental Fig. 2). However, elevated serum IL-6, IL-1 and IL-10 were detected at 
later time points in WT L-arginine-treated mice (72 h), and these levels were 
significantly lower in Stat2-/- mice (Fig 2A).  
Acute pancreatitis led to increased expression of inflammatory genes in pancreatic 
tissue. Consistent with protection from injury, expression of inflammatory genes, TNFα 
and IL-6, was lower in Stat2-/- pancreas compared to WT (Fig 2B) in caerulein- and L-
arginine-induced pancreatitis (Fig 2C).  In contrast, the levels of the anti-inflammatory 
gene IL-10 were higher in PBS-treated control Stat2-/- mice compared to WT and while 
treatment with caerulein increased the expression of IL-10 in WT mice, there was no 
further increase from baseline in Stat2-/-  mice. Therefore, we tested the hypothesis 
that inhibition of TNFα in mice would protect against acute pancreatitis, while 
inhibition of IL-10 would worsen tissue injury in WT mice. In order to study early 
inflammatory and not secondary events, we focused on the hyperacute caerulein 
model. Pre-administration of 100 g i.p TNF blocking antibody resulted in significant 
reduction in serum amylase (6483 iU/ml WT v 4442 iU/ml WT+anti-TNFα, p<0.05) and 
histological injury in WT but not Stat2-/- mice (Fig. 3A-C).  Pre-treatment with 
recombinant TNFα (2 µg i.p.) did not significantly increase serum amylase in caerulein-
treated mice of either genotype (Supplemental Fig. 3).  Pre-treatment with 200 µg i.p 
IL-10-blocking antibody resulted in increased serum amylase (1997 iU/ml WT v 2873 
iU/ml WT+anti-IL-10, p<0.05) and histological injury in WT mice, but did not have an 
effect in Stat2-/- mice (Fig. 3D-F), suggesting that Stat2 acts upstream of production of 
cytokines such as TNFα or IL-10.  
The NF-B family of transcription factors mediates cytokine release following tissue 
injury. To model the activation of NF-B in vitro, we stimulated primary acinar cells 
from WT or Stat2-/- mice with CCK-8, a synthetic octapeptide analogue of caerulein [13, 
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14].  We found a rapid and statistically significant shift from cytoplasmic to nuclear 
localisation of NF-Bp65 at 5 and 15 min in WT cells, whereas in Stat2-/- cells, there was 
little evidence of the oscillation of NF-Bp65 (Fig. 4A-B). Thus in pancreas tissue, Stat2 
influences the cellular localisation of NF-Bp65 and hence cytokine production.   
Loss of Stat2 impairs signalling in damage pathways  
To determine whether Stat2 loss had a more global impact on intracellular signalling 
that leads to cytokine production, we used label-free tandem mass spectrometry to 
study Stat2- and caerulein-dependent phosphoprotein abundance within the 
pancreas. This allowed us to examine the signalling defects that accompany Stat2 loss 
and that are associated with impaired NF-kB localisation. Total protein was extracted 
from WT and Stat2-/- pancreata following treatment with either PBS or caerulein 
(hyperacute model, n=4 in each group) and processed for whole phosphoproteomic 
analysis as previously described [12]. We detected 611 proteins with peptide sequence 
concordance threshold 95% and protein threshold 99.9% (used to confirm the 
presence and identity of a protein).  Based on the expression level of these proteins, 
15 out of 16 samples clustered according to the experimental condition in an 
unsupervised hierarchical clustering algorithm (Fig. 5A and Supplemental Fig. 4).  
Overall the total number of phosphoproteins identified was comparable in each of the 
experimental conditions (Fig. 5B).  
In order to maximise signalling pathway discovery, we used pre-determined thresholds 
for differences of interest at abundance ratios of <0.75 and >1.33.  We identified 348 
unique phosphoproteins that were differently expressed in our experimental 
conditions (Supplemental Table 2). The expression of 257 phosphoproteins was 
altered in WT pancreas as a result of caerulein treatment. In total 175 phosphoproteins 
were altered in caerulein-treated Stat2-/- vs WT pancreas, of which 128 were detected 
in the inflamed but not control samples (66 upregulated and 62 downregulated in 
Stat2-/-). We conducted a GO Panther analysis of all 175 phosphoproteins that were 
differentially expressed between WT and Stat2-/- in unstimulated and in stimulated 
tissue.  This highlighted pathways involved in signalling and the response to injury, 
including the CCK receptor signalling pathway (n=12 phosphoproteins, p=1.1x10-6, 
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Table 1).  Five out of 6 significantly identified pathways contain at least one mitogen-
activated protein (MAP) kinases, including MAP2K2 (MEK2), the principal activator of 
extracellular signal related kinases (ERK1 and ERK2, [15]).  The activating 
phosphorylation of MEK2 at serine S226 was more abundant in inflamed WT pancreata 
compared to Stat2-/- in the phosphoproteome analysis by mass spectrometry (Fig. 5C). 
Using Western blotting, we found that the expression ERK1/2 pT202/Y204, a 
downstream target of MEK2, was also reduced in Stat2-/- nuclear pancreatic extracts 
compared to WT (Supplemental Fig. 5A) [16].  
While we observed no difference in two upstream activators of MEK2 (MKK3 pSer189 
or MKK6 pSer207) between WT and Stat2-/- pancreata (Supplemental Fig. 5B), we did 
find increased levels of Map3K7 (TGF-activated protein kinase 1: Tak1), a MAPKKK 
that lies upstream of MEK2 and NF-kBp65. The phosphorylated Ser412 modification of 
Tak1 was significantly more abundant in Stat2-/- caerulein-treated samples compared 
to other conditions by mass spectrometry (Fig. 5C) and in independent experiments by 
western blot (Fig 5D). This suggests that Ser412-phosphorylation of Tak1 is a potential 
point of pathway interruption in the absence of Stat2.  
Cell-specific effects of Stat2 loss 
To determine the cell type in which Stat2 plays a role, we generated bone marrow 
chimeric mice and found that loss of Stat2 in either donor or recipient cellular 
compartments resulted in lower serum amylase (Fig. 6A) and less histological injury 
(Fig. 6B).  To further refine this, we generated mice with a conditional deletion of 
Stat2 (Stat2flox/flox) induced by Pdx1-cre to specifically delete Stat2 in cells expressing 
Pdx1 (Stat2Δacinar) [17].  Following hyperacute caerulein-induced pancreatitis, the 
expression of inflammatory TNFα was significantly lower in Stat2Δacinar mice 
compared to WT (Fig. 6B), in keeping with the impaired signalling above. However 
this had no significant effect on serum amylase concentration (Fig. 6C) nor pancreatic 
histology (Fig. 6D).  Given that cytokine blockade did modulate pancreatic 
inflammation, these results strongly suggest that Stat2- and cytokine-dependent 
tissue injury in acute pancreatitis is mediated by a combination of bone-marrow-
derived cells and/or non-acinar stromal cells.     
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DISCUSSION  
Our data show that Stat2 has a pathogenic, pro-inflammatory role in the response to 
sterile injury in the pancreas.  In two models, assessed at different time points, Stat2-/- 
mice were protected from caerulein- and L-arginine-induced acute pancreatitis. Using 
a phosphoproteomic approach, we identified signalling mediators from the MAPK 
cascade downstream of, and including, Tak1, that were differentially activated 
between WT and Stat2-/-.  However, acinar cell-specific deletion of Stat2 alone is 
insufficient for histological and biochemical protection from acute pancreatitis, 
suggesting that Stat2 plays a role in non-acinar stromal and/or bone-marrow-derived 
cells.   
Caerulein is believed to cause pancreatitis by supra-physiological activation of CCK1 
and CCK2 receptors, which signal through MAPK intermediates [18]. We have shown 
that in vivo cytokine gene expression in response to caerulein is Stat2-dependent, as is 
NF-B localisation to the nucleus in primary acinar cells. L-arginine does not act 
through CCK receptors, yet Stat2 loss is also protective in this model of pancreatitis. 
We present multiple and complementary data sets to demonstrate that in the absence 
of Stat2, features of acute pancreatitis are improved; histological, immunological 
(cytokine data) and biochemical.  Serum amylase levels indicate the extent of 
pancreatic injury [19] although they do not predict the organs failure other severe 
systemic complications observed in patients with the clinical syndrome of severe acute 
pancreatitis. The mechanism by which L-arginine causes pancreatitis is not fully 
understood but cellular metabolic disturbances liberate damage-associated molecular 
patterns which can trigger MAPK-containing signalling pathways [20, 21].  Thus Stat2 
seems to play a wide role in MAPK-mediated signal transduction in response to injury 
that is agnostic of the initial triggering stimulus.  
The main question that arises from our work is where in these signalling pathways 
Stat2 is acting. The data show an effect on MAPK-mediated signalling, ERK activation 
and NF-B signalling. One interpretation of our results is that Stat2 sits at a common 
point that is proximal in these pathways. A build-up of pS413Tak1 in inflamed 
pancreatic tissue in Stat2-/- mice might suggest that Stat2 is downstream of Tak1 but 
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we have not excluded a compensatory increase in kinases or phosphatases in the 
absence of Stat2 that affects upstream signalling. Similarly we have not demonstrated 
a direct interaction between Stat2 and Tak1 or other mediators of these pathways to 
see if there is physical association.  
We could not recapitulate the protection seen in Stat2-/- mice by blocking type I IFN 
signalling. Indeed, at the same early time points assessed in the current study, no 
difference in pancreatic damage was observed between WT and Ifnar1-/- mice [22]. 
This suggests that IFN-mediated signals are not required for early pancreatitis and 
earlier work has shown that cellular responses to epidermal growth factor [23] and LPS 
[4] are mediated by Stat2 even in the absence of the IFN phosphorylation site at 
Tyr689.  Previous studies into the role for type I IFN signalling in acute pancreatitis have 
used prolonged injection schedules and focussed on much later time points after the 
final injection (3-7 days).   In these models, deletion of Ifnar1 partially improved tissue 
injury without an effect on cytokine mRNA levels [8, 22].  Conversely, we find that 
pancreas-specific deletion of Stat2 reduces TNFα levels but has no effect on tissue 
injury.  While pre-treatment with a TNFα blocking antibody attenuated injury in WT 
mice, it had no effect on the Stat2-/-.  The absence of an effect of pre-treatment with 
recombinant TNFα may reflect saturation or intact regulatory and control mechanisms.  
The lack of an effect in Stat2-/- relates to the known defects in TNFα-responses in the 
absence of Stat2 [4].  Taken together, these data emphasise the IFN-independent role 
for Stat2 in AP and challenge the dogma that cytokine production is an obligate 
determinant of tissue injury.  Nevertheless, we show that specific cytokine modulation 
does alter the severity of tissue inflammation and the main effect of Stat2 is to mediate 
signalling that leads to NF-B activation.   
A consensus has yet to be reached on whether NF- B activation is protective or 
deleterious in acute pancreatitis [24, 25].  This is largely because NF- B activation is 
the result of the timely integration of multiple pathways and NF- B itself can activate 
pro- and anti-inflammatory downstream effectors [26].  Pancreas-specific mutants of 
NF-Bp65 that are unable to dimerise or translocate to the nucleus resulted in more 
severe caerulein-induced injury [27] and deletion of IBa, which results in reduced 
activation of NF-Bp65 and reduced caerulein-induced acute pancreatitis [25]. 
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Conversely, conditional overexpression of NF-B or constitutively active IKK2 increased 
activity of NF-B in acinar cells, and led to more severe pancreatitis compared to 
control mice [24].  Stat2 deficiency in our models is constitutive rather than inducible, 
but we do show that the absence of Stat2 is associated with disrupted nuclear entry 
and exit of NF-Bp65.  This finding is complementary to our previous working showing 
a role for Stat2 in response to the pathogen-associated molecular pattern 
lipopolysaccharide; a model of infective inflammation [4]. We have not over-expressed 
Stat2, so do not know if this results in NF-B over-activation nor the effects that this 
would have on severity. Our results suggest that at early time points, NF-B related 
signalling and gene expression do contribute to disease severity hence early cytokine 
inhibition alters the disease course. The protective effect of TNFα inhibition is of clinical 
as well as pathogenic interest and a clinical trial of infliximab versus placebo in patients 
with acute severe pancreatitis is currently underway.  Our data certainly support the 
hypothesis that early inhibition of TNFα can be beneficial in pancreatitis, but further 
work is needed to determine the characteristics of patients who will benefit and the 
timing of treatment to maximise efficacy and minimise potential side effects such as 
sepsis. We have shown that IFN-independent, Stat2-dependent signalling leads to the 
timely activation of NF-B in models of sterile pancreatic inflammation. Strategies that 
target Stat2 or its associated signalling mediators may have a therapeutic role in acute 
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Table 1. Signalling pathways identified by GO Panther pathway analysis to be statistically 
significantly enriched in 278 phosphoproteins that differed between WT and Stat2-/- 
pancreata either at baseline or after treatment with caerulein.  
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Figure 1.  Stat2 loss reduces the severity of experimental pancreatitis in two models.  (A) 
Serum concentration of amylase and (B) representative haematoxylin and eosin-stained 
histology following injection with ceruelin at the time points indicated (hyperacute = 1 h 
after 4 hourly injections and acute = 24 h after 7 hourly injections).  Effect of Ifnar1 blocking 
antibody (IFN) on (C) IFN-induced (IFN) Mx1 gene expression and (D) caerulein-induced 
serum amylase expression.  (E) Serum concentration of amylase and (F) histology following 
injection with L-arginine at the time points indicated.  WT – wild type, KO - Stat2-/-, PBS – 
phosphate buffered saline, ***p<0.001, *p<0.05, ns – not significant. 
Figure 2. The effect of Stat2 loss on cytokine production.  (A) Serum cytokine 
concentrations in wild type (WT) and Stat2-/- (KO) mice following treatment with PBS or L-
arginine. RNA expression of genes shown in wild type (WT) and Stat2-/- (KO) whole 
pancreata following treatment with PBS (P) or caerulein (C) in (B) hyperacute (1 h after 4 
hourly injections) caerulein- or (c) L-arginine-induced pancreatitis at time points indicated. 
*p<0.05. 
Figure 3. Effects of blocking TNFα and IL-10 on caerulein-induced pancreatitis.  Wild type 
(WT) and Stat2-/- (KO) mice were given a single intraperitoneal injection of (A-C) 100 g 
TNF blocking antibody or (D-F) 200 µg IL-10-blocking antibody prior to PBS or cerulein 
treatment at the time points indicated (hyperacute = 1 h after 4 hourly injections and acute 
= 24 h after 7 hourly injections).  (A,D) Serum amylase, (B,E) tissue injury score are shown 
for each pre-treatment and (C,F) representative haematoxylin and eosin-stained histology. 
*p<0.05 
Figure 4. Loss of Stat2 disrupts NF-B nuclear localisation.  (A) Confocal microscopy 
showing NF-Bp65 staining (green) and nuclear DAPI (blue) in primary pancreatic cells at the 
timepoints shown following stimulation with CCK-8.  (B) IMARIS software quantification of 
nuclear localization of NF-Bp65 signal in confocal images.  WT – wild type, KO - Stat2-/- 
Figure 5. Global phosphoproteomic changes associated with Stat2 loss.  22,663 tandem 
mass spectra were identified, corresponding to 2881 unique peptide ions, of which 1650 
were phosphopeptides containing 1771 phosphopeptide sites. (A) unsupervised hierarchical 
clustering of 611 phosphoproteins identified using label-free mass spectrometry.  Each lane 
represents an individual mouse and each row is one phosphoprotein. Yellow indicates high 
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abundance and black lowest abundance. (B) Total number of phosphoproteins identified in 
each experimental condition.  WT – wild type, KO - Stat2-/-, PBS – phosphate buffered saline. 
(C) Abundance of key signalling phosphoproteins as determined by mass spectrometry. (D) 
Western blot for phosphorylated Tak1 (80 kDa), total Tak1 (80 kDa) and -actin (45 kDa) in 
whole cell extracts and taken from wild type (WT) and Stat2-/- whole pancreata following 
treatment with PBS or caerulein in the hyperacute model (1 h after 4 hourly injections).   
 Figure 6. Effects of lineage Stat2 deletion in specific compartments on caerulein-induced 
pancreatitis  (A) Serum concentration of amylase and (B) representative haematoxylin and 
eosin-stained histology in bone-marrow chimeric mice following hyperacute caerulein-
induced pancreatitis (1 h after 4 hourly injections).  (C) RNA expression of TNF in whole 
pancreatic extracts, (D) serum concentration of amylase and (E) representative 
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